Skip to main content
. 2019 Nov 28;29:101392. doi: 10.1016/j.redox.2019.101392

Fig. 7.

Fig. 7

Effects of oroxylin A on the tumorigenicity in SMMC-7721 cells in vivo. (A) Tumor volume of control and oroxylin A treatment groups in SMMC-7721 cells or in knockdown of p62 SMMC-7721 cells were measured and calculated once every 3 days. (B) Images of SMMC-7721 tumors from indicated group on day 21. (C) Weight of tumor in control and oroxylin A treatment groups. Data are presented as mean ± SD. *P < 0.05, **P < 0.01.